Companies: 10,795·Total market cap: $144.5T
Biotest AG

Biotest AG

BIESFOTCHealthcare
$32.00
+$0.00(+0.00%)
Market Cap$1.6B
P/E Ratio
52W High$32
52W Low$30.48
Overview

Biotest AG (BIESF) · Cash Flow

Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.

FMP · BIESF · as of 2026-06-10

Financial statements

Operating CF · CapEx · Free Cash Flow
Breakdown2024-122023-122022-122021-122020-12
Operating Activities
Net Income$0.03B$0.13B$0.03B($0.06B)($0.03B)
Depreciation & Amort.$0.04B$0.04B$0.04B$0.03B$0.03B
Stock-Based Comp.$0.00B$0.00B$0.00B$0.00B$0.00B
Change in Working Capital($0.00B)($0.17B)($0.05B)$0.02B($0.03B)
Net Cash from Operations$0.06B($0.00B)($0.04B)$0.03B($0.02B)
Investing Activities
Capital Expenditure($0.03B)($0.03B)($0.03B)($0.02B)($0.03B)
Purchases of Investments$0.00B$0.00B$0.00B$0.00B$0.00B
Sales of Investments$0.00B$0.00B$0.00B$0.00B$0.01B
Net Cash from Investing($0.03B)$0.00B($0.04B)($0.02B)($0.01B)
Financing Activities
Common Stock Repurchased$0.00B$0.00B$0.00B$0.00B$0.00B
Dividends Paid($0.00B)$0.00B($0.00B)($0.00B)($0.00B)
Debt Issued / Repaid($0.03B)($0.01B)$0.10B$0.02B$0.05B
Net Cash from Financing($0.04B)($0.01B)$0.09B$0.02B$0.04B
Free Cash Flow
Free Cash Flow$0.03B($0.04B)($0.07B)$0.02B($0.04B)
FCF Margin %(computed)4.43%-5.27%-13.52%3.04%-9.03%

Data source: Financial Modeling Prep · Last updated: 2026-06-10 · EUR · B

Explore more Biotest AG data

About Biotest AG (BIESF) Cash Flow Statement

Biotest AG generated operating cash flow of $0.06B and free cash flow of $0.03B for 2024 — a FCF margin of 4.43%. Capital expenditure was ($0.03B).

Frequently asked questions

BIESF · 4 questions

Biotest AG generated free cash flow of $0.03B for 2024, up 189.2% year-over-year.

BIESF free cash flowFCF margincash flow yield

· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10